Fei (FEIC) 8-K Results of Operations and Financial Condition

Exhibit 99.1

NEWS RELEASE

For more information contact:

FEI Company

Fletcher Chamberlin

Investor Relations

(503) 726-7710

fletcher.chamberlin@fei.com

FEI Company Reports Fourth-Quarter Financial Results

Record Quarterly and Annual Revenue and Income

HILLSBORO, Ore., February 4, 2008   — FEI Company (NASDAQ: FEIC) reported 2007 annual revenue that was 24% higher and net income that was nearly three times greater than in 2006. Fourth quarter revenue grew both sequentially and year-over-year, as did quarterly net income, which was aided in the latest quarter by a tax benefit.

Net sales for the quarter ended December 31, 2007 of $152.5 million were up 5% compared to the third quarter of 2007 and 9% compared to the fourth quarter of 2006. Bookings in the quarter totaled $156.3 million, up 2% compared with $153.3 million in the third quarter of 2007 and down 9% from the record level of $171.7 million for the fourth quarter of 2006. The book-to-bill ratio for the latest quarter was 1.02 to 1.00. The backlog at the end of the quarter was $309.4 million, of which over 90% is expected to ship by the end of the fourth quarter of 2008.

Income from continuing operations for the fourth quarter of 2007 was $17.2 million, compared with $13.4 million in the third quarter of 2007 and $11.9 million in last year’s fourth quarter. Diluted earnings per share from continuing operations in the latest quarter were $0.40, compared with $0.31 in the third quarter of 2007 and $0.30 in the fourth quarter of 2006. The gross profit margin was 40.7 % in the fourth quarter of 2007, compared with 42.0% in both the third quarter of 2007 and the prior year’s fourth quarter.

The company recorded a tax benefit of $4.0 million in the fourth quarter of 2007, due mainly to the completion of various international tax audits. The tax benefit increased fourth quarter 2007 net income and net income per share from continuing operations by approximately $6.7 million and $0.15 per share, respectively.

1

“The strength of our market and geographic diversity was evident in the fourth quarter,” said Don Kania, president and CEO of FEI. “Bookings were up sequentially and were the second highest quarterly total in our history. Revenue was the highest for a single quarter ever, and capped a year of 24% growth. Revenue has grown at a 12% compound growth rate in the last five years, and our target is to continue to grow at least that rapidly over the next five years.

“We made three important announcements in early 2008 that reflect important parts of our strategy,” continued Kania. “In January, we retired the $45.9 million balance of our 5.5% convertible notes, highlighting the company’s solid cash-generating capabilities. Also in January we announced the opening of our latest NanoPort applications center in Shanghai, China, as part of our strategic investment to expand our business in Asia. Today we announced the introduction of the Titan Krios™, which expands our industry-leading transmission electron microscope performance into life science applications. The Krios reflects both the strategic importance of extending our technology leadership as well as the opportunities we see to tap the growth in our NanoBiology market segment.”

Bookings and revenue comparisons for the company’s market segments and other data are included in the supplementary information attached to this release, along with detailed statements of operations and balance sheets.

The company’s balance sheet remained strong. Total cash and investments at the end of the quarter were $491.0 million, up $35.2 million from the beginning of the quarter and up $84.9 million for the full year. Convertible debt at the end of the quarter remained unchanged at $310.9 million; that total was reduced by $45.9 million in January, 2008. Shareholders’ equity at the end of the fourth quarter was $489.0 million, an increase of $32.3 million in the quarter and $139.1 million for the full year.

First Quarter 2008 Guidance

FEI currently expects net sales for the first quarter of 2008 to be in the range of $145 million to $152 million. Bookings are expected to be above $145 million, and earnings are expected to be in the range of $0.18 to $0.25 per share, assuming a 25% tax rate.

Investor Conference Call  — 2:00 p.m. PST Monday, February 4, 2008

Parties interested in listening to FEI’s quarterly conference call may do so by dialing 1-800-218-4007 (domestic, toll-free) or 1-303-262-2130 (international) and asking for the FEI Q4 Earnings call. The call can also be accessed via the web by going to FEI’s Investor Relations page at

2

www.fei.com, where the webcast will also be archived. A telephone replay of the call will also be accessible for one month by dialing 1-800-405-2236 (US) or 1-303-590-3000 (international) and entering the access code 11107863#.

About FEI

FEI (Nasdaq: FEIC) is a global leader in providing innovative instruments for nanoscale imaging, analysis and prototyping. FEI focuses on delivering solutions that provide groundbreaking results and accelerate research, development and manufacturing cycles for its customers in semiconductor and data storage, academic and industrial R&D and life sciences markets. With R&D centers in North America and Europe, and sales and service operations in more than 50 countries around the world, FEI’s Tools for Nanotech™ are bringing the nanoscale within the grasp of leading researchers and manufacturers. More information can be found online at: www.fei.com.

Safe Harbor Statement

These financial results are subject to completion of our year-end audit. In addition, this news release contains forward-looking statements that include our guidance for the first quarter of 2008, the expected shipment of our backlog, plans for further geographic expansion, expectations for future bookings, market and revenue growth and the impact of new product introductions. Factors that could affect these forward-looking statements include, but are not limited to, the strength of the NanoResearch and Industry, NanoElectronics and NanoBiology segments; cyclical changes in the data storage and semiconductor industries, which are the major components of the NanoElectronics market; fluctuations in foreign exchange, interest and tax rates; our continued ability to maintain deferral accounting of hedge transactions; reduced profitability due to failure to achieve or sustain margin improvement in service or product manufacturing; the relative mix of higher-margin and lower-margin products; inability to produce a higher volume of products with existing personnel or facilities; risks associated with shipping a high percentage of the company’s quarterly revenue in the last month of the quarter; difficulty in obtaining parts from suppliers; inability to achieve cost reductions in manufacturing or other areas; lower than expected customer orders; cancellation of customer orders; customer requests to defer planned shipments; failure of customers to adopt new technologies; increased competition and new product offerings from competitors; lower average sales prices and reduced margins on some product sales due to increased competition; failure of the company’s products and technology to find acceptance with customers; delays in shipping products for technical performance, component supply or other reasons; unfavorable business conditions and lack of growth in the general economy, both domestic and foreign; potential restructurings and reorganizations not presently anticipated; reduced sales due to geopolitical risks; changes in trade policies and tariff regulations; changes in the regulatory environment in the nations where we do business; inability to overcome technological barriers; additional selling, general and administrative or research and development expenses; additional costs related to future merger and acquisition activity; and failure of the company to achieve anticipated benefits of future acquisitions, including failure to achieve financial goals and integrate the acquisitions successfully. Please also refer to our Form 10-K, Forms 10-Q, Forms 8-K and other filings with the U.S. Securities and Exchange Commission for additional information on these factors and other factors that could cause actual results to differ materially from the forward-looking statements. FEI assumes no duty to update forward-looking statements.

3

FEI Company and Subsidiaries

Consolidated Balance Sheets

(In thousands)

(Unaudited)

	December 31,		September 30,		December 31,
	2007		2007		2006
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$	280,593	$	222,419	$	110,656
Short-term investments in marketable securities	152,041		198,362		234,202
Short-term restricted cash	20,984		12,973		20,172
Receivables	159,457		176,468		144,955
Inventories	138,762		137,243		97,470
Deferred tax assets	4,788		4,996		4,386
Other current assets	36,273		40,941		33,474
Total current assets	792,898		793,402		645,315
Non-current investments in marketable securities	12,758		12,708		34,900
Long-term restricted cash	24,621		9,298		6,131
Non-current service inventories	42,168		41,134		37,920
Property plant and equipment, net	74,700		68,083		60,394
Purchased technology, net	2,862		3,268		4,494
Goodwill	40,864		40,875		40,900
Deferred tax assets	2,641		9,479		542
Other assets, net	16,834		19,141		7,483
TOTAL	$	1,010,346	$	997,388	$	838,079
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable	$	31,156	$	50,083	$	45,118
Accrued payroll liabilities	26,544		26,212		20,736
Accrued warranty reserves	6,585		6,902		5,716
Accrued agent commissions	9,119		6,871		6,175
Deferred revenue	72,551		61,564		48,992
Income taxes payable	3,403		6,987		9,203
Accrued restructuring, reorganization and relocation	580		598		2,439
Current portion of convertible debt	195,882		45,882		—
Other current liabilities	29,266		31,241		29,276
Total current liabilities	375,086		236,340		167,655
Convertible debt	115,000		265,000		310,882
Deferred tax liabilities	4,479		4,204		4,062
Other liabilities	26,776		35,119		5,572
SHAREHOLDERS’ EQUITY:
Preferred stock - 500 shares authorized; none issued and outstanding	—		—		—
Common stock - 70,000 shares authorized; 36,405, 36,252 and 34,052 shares issued and outstanding at December 31, 2007, September 30, 2007 and December 31, 2006	395,904		390,168		348,479
Retained earnings (accumulated deficit)	28,009		10,533		(36,041		)
Accumulated other comprehensive income	65,092		56,024		37,470
Total shareholders’ equity	489,005		456,725		349,908
TOTAL	$	1,010,346	$	997,388	$	838,079

FEI Company and Subsidiaries

Consolidated Statements of Operations

(In thousands, except per share amounts)

(Unaudited)

	Thirteen Weeks Ended									Year Ended
	December 31,			September 30,			December 31,			December 31,			December 31,
	2007			2007			2006			2007			2006
NET SALES:
Products	$	119,275		$	113,565		$	107,822		$	466,425		$	360,643
Service and components	33,270			32,223			32,462			128,422			118,848
Total net sales	152,545			145,788			140,284			594,847			479,491
COST OF SALES:
Products	65,995			61,249			58,499			252,546			197,742
Service and components	24,525			23,307			22,880			93,544			85,303
Total cost of sales	90,520			84,556			81,379			346,090			283,045
Gross profit	62,025			61,232			58,905			248,757			196,446
OPERATING EXPENSES:
Research and development	18,222			16,414			16,112			66,105			57,528
Selling, general and administrative	33,865			30,915			28,508			124,526			100,279
Amortization of purchased technology	450			444			438			1,777			2,034
Merger costs	—			—			—			—			484
Restructuring, reorganization and relocation	132			—			(27		)	(272		)	12,609
Asset impairment	—			—			—			—			465
Total operating expenses	52,669			47,773			45,031			192,136			173,399
OPERATING INCOME	9,356			13,459			13,874			56,621			23,047
OTHER INCOME (EXPENSE):
Interest income	6,498			5,902			4,154			22,372			13,150
Interest expense	(2,444		)	(2,218		)	(2,110		)	(8,735		)	(7,355		)
Gain on investment disposals and impairment, net	—			511			—			1,167			—
Other expense, net	(230		)	(1,034		)	(538		)	(3,492		)	(723		)
Total other income, net	3,824			3,161			1,506			11,312			5,072
INCOME FROM CONTINUING OPERATIONS BEFORE TAXES	13,180			16,620			15,380			67,933			28,119
INCOME TAX EXPENSE (BENEFIT)	(4,034		)	3,236			3,481			8,374			10,467
INCOME FROM CONTINUING OPERATIONS	17,214			13,384			11,899			59,559			17,652
DISCONTINUED OPERATIONS:
Gain (loss) from discontinued operations	—			—			(580		)	—			(947		)
Gain on disposal, net of income taxes	263			—			3,335			390			3,335
INCOME FROM DISCONTINUED OPERATIONS	263			—			2,755			390			2,388
NET INCOME	$	17,477		$	13,384		$	14,654		$	59,949		$	20,040
BASIC NET INCOME PER SHARE DATA:
From continuing operations	$	0.47		$	0.37		$	0.35		$	1.67		$	0.52
From discontinued operations	$	0.01		$	0.00		$	0.08		$	0.01		$	0.07
DILUTED NET INCOME PER SHARE DATA:
From continuing operations	$	0.40		$	0.31		$	0.30		$	1.39		$	0.47
From discontinued operations	$	0.01		$	0.00		$	0.06		$	0.01		$	0.06
WEIGHTED AVERAGE SHARES OUTSTANDING:
Basic	36,323			36,216			33,886			35,709			33,818
Diluted	46,477			46,419			44,079			46,254			39,752

FEI Company and Subsidiaries

Consolidated Statements of Operations

(Unaudited)

	Thirteen Weeks Ended (1)						Year Ended (1)
	December 31,		September 30,		December 31,		December 31,		December 31,
	2007		2007		2006		2007		2006
NET SALES:
Products	78.2	%	77.9	%	76.9	%	78.4	%	75.2	%
Service	21.8	%	22.1	%	23.1	%	21.6	%	24.8	%
Total net sales	100.0	%	100.0	%	100.0	%	100.0	%	100.0	%
COST OF SALES:
Products	43.3	%	42.0	%	41.7	%	42.5	%	41.2	%
Service	16.1	%	16.0	%	16.3	%	15.7	%	17.8	%
Total cost of sales	59.3	%	58.0	%	58.0	%	58.2	%	59.0	%
Gross profit	40.7	%	42.0	%	42.0	%	41.8	%	41.0	%
OPERATING EXPENSES:
Research and development	11.9	%	11.3	%	11.5	%	11.1	%	12.0	%
Selling, general and administrative	22.2	%	21.2	%	20.3	%	20.9	%	20.9	%
Amortization of purchased technology	0.3	%	0.3	%	0.3	%	0.3	%	0.4	%
Restructuring, reorganization and relocation	0.1	%	0.0	%	0.0	%	0.0	%	2.6	%
Asset impairment	0.0	%	0.0	%	0.0	%	0.0	%	0.1	%
Merger costs	0.0	%	0.0	%	0.0	%	0.0	%	0.0	%
Total operating expenses	34.5	%	32.8	%	32.1	%	32.3	%	36.2	%
OPERATING INCOME	6.1	%	9.2	%	9.9	%	9.5	%	4.8	%
OTHER INCOME (EXPENSE):
Interest income	4.3	%	4.0	%	3.0	%	3.8	%	2.7	%
Interest expense	-1.6	%	-1.5	%	-1.5	%	-1.5	%	-1.5	%
Gain on investment disposals and impairment, net	0.0	%	0.4	%	0.0	%	0.2	%	0.0	%
Other expense, net	-0.2	%	-0.7	%	-0.4	%	-0.6	%	-0.2	%
Total other expense, net	2.5	%	2.2	%	1.1	%	1.9	%	1.1	%
INCOME FROM CONTINUING OPERATIONS BEFORE TAXES	8.6	%	11.4	%	11.0	%	11.4	%	5.9	%
INCOME TAX EXPENSE (BENEFIT)	-2.6	%	2.2	%	2.5	%	1.4	%	2.2	%
INCOME FROM CONTINUING OPERATIONS	11.3	%	9.2	%	8.5	%	10.0	%	3.7	%
DISCONTINUED OPERATIONS:
Loss from discontinued operations	0.0	%	0.0	%	-0.4	%	0.0	%	-0.2	%
Gain on disposal, net of income taxes	0.2	%	0.0	%	2.4	%	0.1	%	0.7	%
INCOME FROM DISCONTINUED OPERATIONS	0.2	%	0.0	%	2.0	%	0.1	%	0.5	%
NET INCOME	11.5	%	9.2	%	10.4	%	10.1	%	4.2	%

(1) Percentages may not add due to rounding.

FEI COMPANY

Supplemental Data Table 1

($ in millions, except per share amounts)

(Unaudited)

	Q4 Ended			Q3 Ended			Q4 Ended
	12/31/2007			9/30/2007			12/31/2006
Income Statement Highlights
Consolidated sales	$	152.6		$	145.8		$	140.3
Gross margin	40.7		%	42.0		%	42.0		%
R&D spending	$	18.2		$	16.4		$	16.1
R&D (% of sales)	11.9		%	11.3		%	11.5		%
SG&A	$	33.9		$	30.9		$	28.5
SG&A (% of sales)	22.2		%	21.2		%	20.3		%
Stock compensation expense - COGS	$	0.4		$	0.2		$	0.2
Stock compensation expense - R&D	$	0.3		$	0.3		$	0.2
Stock compensation expense - SG&A	$	1.5		$	0.7		$	1.4
Net income from continuing operations	$	17.2		$	13.4		$	11.9
Net income from discontinued operations	$	0.3		$	0.0		$	2.8
Net income	$	17.5		$	13.4		$	14.7
Diluted earnings per share from continuing operations	$	0.40		$	0.31		$	0.30
Diluted earnings per share from discontinued operations	$	0.01		$	0.00		$	0.06
Interest income add back included in the calculation of diluted EPS	$	1.2		$	1.2		$	1.2
Sales by Market Segment
NanoElectronics	$	33.0		$	48.1		$	42.4
NanoResearch & Industry	$	67.8		$	51.6		$	55.3
NanoBiology	$	18.5		$	13.9		$	10.1
Service and Components	$	33.3		$	32.2		$	32.5
Sales by Geography
North America	$	63.7		$	46.5		$	49.9
Europe	$	65.7		$	61.5		$	52.2
Asia Pacific	$	23.2		$	37.8		$	38.2
Bookings
Total	$	156.3		$	153.3		$	171.7
Book-to-bill ratio	1.02			1.05			1.22
Backlog - total	$	309.4		$	305.7		$	305.9
Backlog - Service and Components	$	54.7		$	58.5		$	46.8
Bookings by Market Segment
NanoElectronics	$	39.6		$	28.8		$	49.7
NanoResearch & Industry	$	63.2		$	80.2		$	65.1
NanoBiology	$	24.0		$	11.2		$	23.9
Service and Components	$	29.5		$	33.1		$	33.0
Balance Sheet Highlights
Cash, equivalents, investments, restricted cash	$	491.0		$	455.8		$	406.1
Operating cash generated (used)	$	34.8		$	11.4		$	24.4
Accounts receivable	$	159.5		$	176.5		$	145.0
Days sales outstanding (DSO)	95			110			94
Inventory turnover	2.6			2.6			3.5
Inventories	$	138.8		$	137.2		$	97.5
Property, plant and equipment	$	74.7		$	68.1		$	60.4
Fixed asset investment (during quarter)	$	7.3		$	5.1		$	2.1
Depreciation expense	$	3.8		$	3.4		$	3.3
Current liabilities	$	375.1		$	236.3		$	167.7
Working capital	$	417.8		$	557.1		$	477.7
Shareholders’ equity	$	489.0		$	456.7		$	349.9
Headcount (permanent and temporary)	1,866			1,851			1,683